Powe et al identify that higher placental expression of GKN1 is associated with diminished beta cell function in pregnancy and GDM link.springer.com/article/10.1... @cepowemd.bsky.social

Our study on use and discontinuation of GLP-1 receptor agonists before and in early pregnancy was published today in JAMA. We owe it to our patients to begin the hard work of safely and rigorously delivering the advances in novel therapeutics for management of weight and glycemia to pregnancy.